GTHP Stock Chart & Stats
$0.23
-$0.02(-7.92%)
At close: 4:00 PM EDT
$0.23
-$0.02(-7.92%)
Day’s Range― - ―
52-Week Range$0.15 - $0.54
Previous CloseN/A
Volume3.05K
Average Volume (3M)9.81K
Market Cap
$19.31M
Enterprise Value$24.66M
Total Cash (Recent Filing)$12.00K
Total Debt (Recent Filing)$2.79M
Price to Earnings (P/E)―
Beta1.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding96,537,346
10 Day Avg. Volume13,756
30 Day Avg. Volume9,806
Financial Highlights & Ratios
PEG Ratio2.29
Price to Book (P/B)-7.05
Price to Sales (P/S)55.21
P/FCF Ratio-39.57
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue37.94
Enterprise Value/Gross Profit59.28
Enterprise Value/Ebitda-9.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guided Therapeutics News
GTHP FAQ
What was Guided Therapeutics Inc’s price range in the past 12 months?
Guided Therapeutics Inc lowest stock price was $0.15 and its highest was $0.54 in the past 12 months.
What is Guided Therapeutics Inc’s market cap?
Guided Therapeutics Inc’s market cap is $19.31M.
When is Guided Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Guided Therapeutics Inc’s earnings last quarter?
Guided Therapeutics Inc released its earnings results on Nov 13, 2023. The company reported -$0.014 earnings per share for the quarter.
Is Guided Therapeutics Inc overvalued?
According to Wall Street analysts Guided Therapeutics Inc’s price is currently Overvalued.
Does Guided Therapeutics Inc pay dividends?
Guided Therapeutics Inc does not currently pay dividends.
What is Guided Therapeutics Inc’s EPS estimate?
Guided Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics Inc have?
Guided Therapeutics Inc has 96,537,346 shares outstanding.
What happened to Guided Therapeutics Inc’s price movement after its last earnings report?
Guided Therapeutics Inc reported an EPS of -$0.014 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guided Therapeutics Inc?
Currently, no hedge funds are holding shares in GTHP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Technical Analysis
Co-Diagnostics
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Movano
―
Nexalin Technology, Inc.
―